A Novel Blood Test as a Biomarker in Mental Health
Not yet recruitingOBSERVATIONAL
Enrollment
500
Participants
Timeline
Start Date
March 15, 2025
Primary Completion Date
March 15, 2026
Study Completion Date
March 15, 2026
Conditions
Depression - Major Depressive DisorderSchizophenia DisorderPsychosisMania (Neurotic)Alcohol ConsumptionAnxiety Disorder (Panic Disorder or GAD)Substance Use DisordersAlcohol Use Disorder
Trial Locations (1)
V3L 3M2
Royal Columbian Hospital, New Westminster
All Listed Sponsors
collaborator
Royal Columbian Hospital Foundation
OTHER
lead
Steve Reynolds
OTHER
NCT06856161 - A Novel Blood Test as a Biomarker in Mental Health | Biotech Hunter | Biotech Hunter